The court filing for Massachusetts stated, "Purdue determined that opioid savings cards worked like the teaser rate on a long-term and very high-stakes mortgage."
The court document from Massachusetts asserted that Purdue Pharmaceuticals found opioid savings cards to be comparable to a teaser rate on a long-term and extremely risky mortgage.